Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $180,794 | 37 | 59.8% |
| Consulting Fee | $119,024 | 20 | 39.3% |
| Food and Beverage | $2,685 | 93 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $102,734 | 19 | $0 (2018) |
| Boehringer Ingelheim Limited | $65,350 | 7 | $0 (2017) |
| Janssen Research & Development, LLC | $51,549 | 12 | $0 (2018) |
| Ortho-Clinical Diagnostics, Inc. | $45,845 | 9 | $0 (2024) |
| Quidel Corporation | $34,340 | 10 | $0 (2023) |
| Medtronic, Inc. | $788.18 | 43 | $0 (2024) |
| ABIOMED | $485.99 | 13 | $0 (2024) |
| Medtronic Vascular, Inc. | $363.73 | 13 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $197.56 | 3 | $0 (2019) |
| Boston Scientific Corporation | $196.51 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,511 | 34 | Ortho-Clinical Diagnostics, Inc. ($45,845) |
| 2023 | $34,968 | 36 | Quidel Corporation ($34,340) |
| 2022 | $195.24 | 9 | Medtronic, Inc. ($85.48) |
| 2021 | $102.27 | 4 | ABIOMED ($71.87) |
| 2020 | $60.77 | 4 | Medtronic Vascular, Inc. ($39.43) |
| 2019 | $394.83 | 12 | AstraZeneca Pharmaceuticals LP ($105.97) |
| 2018 | $70,605 | 20 | AbbVie, Inc. ($43,170) |
| 2017 | $149,664 | 31 | Boehringer Ingelheim Limited ($65,350) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Renal Denervation System | ||||||
| 11/19/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Renal Denervation System | ||||||
| 11/13/2024 | Ortho-Clinical Diagnostics, Inc. | Triage (Device) | — | Cash or cash equivalent | $170.00 | Research |
| Study: Savanna RVP4 plus Assay • Category: DIAGNOSTICS | ||||||
| 11/11/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Renal Denervation System | ||||||
| 10/21/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Renal Denervation System | ||||||
| 09/19/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Renal Denervation System | ||||||
| 09/11/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $4,950.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 09/11/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $675.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 08/27/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Lithoplasty | ||||||
| 08/21/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 07/31/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 07/18/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Coronary | ||||||
| 07/02/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 07/01/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Renal Denervation System | ||||||
| 06/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Renal Denervation System | ||||||
| 06/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $66.33 | General |
| Category: Renal Denervation System | ||||||
| 06/06/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Renal Denervation System | ||||||
| 06/05/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Renal Denervation System | ||||||
| 05/17/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Transcatheter Valve Systems | ||||||
| 05/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $40.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Renal Denervation System | ||||||
| 05/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $177.50 | General |
| Category: General - Vascular Access_IC | ||||||
| 05/01/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 04/10/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M11-352 | AbbVie, Inc. | $101,822 | 13 |
| VITROS Immunodiagnostic Products hs Troponin I | Ortho-Clinical Diagnostics, Inc. | $43,125 | 7 |
| CS-0908-01-High Note | Quidel Corporation | $32,215 | 9 |
| TriageTrue high sensitivity Troponin | Ortho-Clinical Diagnostics, Inc. | $2,550 | 1 |
| Savanna RVP4 plus Assay | Ortho-Clinical Diagnostics, Inc. | $170.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 921 | 1,028 | $285,730 | $71,604 |
| 2022 | 10 | 855 | 991 | $206,951 | $60,617 |
| 2021 | 13 | 869 | 986 | $243,455 | $70,655 |
| 2020 | 14 | 683 | 785 | $215,762 | $58,261 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 145 | 163 | $43,700 | $17,123 | 39.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 39 | 40 | $42,800 | $8,693 | 20.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 18 | $36,180 | $8,532 | 23.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 56 | 60 | $29,760 | $6,243 | 21.0% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 21 | $28,140 | $6,000 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 55 | $15,040 | $5,029 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 34 | 34 | $14,618 | $4,539 | 31.1% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 21 | $18,417 | $3,270 | 17.8% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $17,940 | $2,813 | 15.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 32 | $6,053 | $2,102 | 34.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 252 | 295 | $8,850 | $1,809 | 20.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 149 | 160 | $6,400 | $1,674 | 26.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 13 | 16 | $10,720 | $1,251 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $2,492 | $1,132 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $2,430 | $970.32 | 39.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 69 | 73 | $2,190 | $423.36 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 146 | 166 | $36,925 | $17,135 | 46.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 35 | 35 | $37,450 | $7,800 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 72 | $16,110 | $7,755 | 48.1% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 48 | 49 | $24,304 | $5,089 | 20.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 31 | 31 | $11,005 | $4,204 | 38.2% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 13 | 13 | $17,420 | $4,125 | 23.7% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 22 | 22 | $19,294 | $4,011 | 20.8% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 13 | 13 | $19,435 | $3,251 | 16.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 38 | $7,068 | $3,225 | 45.6% |
About Dr. Daniel Kolansky, MD
Dr. Daniel Kolansky, MD is a Internal Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124054812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kolansky, MD has received a total of $302,502 in payments from pharmaceutical and medical device companies, with $46,511 received in 2024. These payments were reported across 150 transactions from 21 companies. The most common payment nature is "" ($180,794).
As a Medicare-enrolled provider, Kolansky has provided services to 3,328 Medicare beneficiaries, totaling 3,790 services with total Medicare billing of $261,137. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Philadelphia, PA
- Active Since 06/24/2006
- Last Updated 09/16/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124054812
Products in Payments
- PRADAXA (Drug) $65,350
- INVOKANA (Drug) $51,549
- VITROS (Device) $43,125
- Triage (Device) $34,935
- Impella (Device) $485.99
- ONYX FRONTIER (Device) $318.67
- SYMPLICITY G3 (Device) $283.37
- Resolute (Device) $243.95
- LifeVest (Device) $197.56
- CoreValve Evolut (Device) $134.25
- Coronary Orbital Atherectomy System (Device) $98.04
- Glidesheath (Device) $94.01
- COREVALVE EVOLUT R (Device) $80.02
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $77.43
- RESOLUTE ONYX (Device) $65.48
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $58.27
- FFRANGIO (Device) $24.31
- LANGSTON (Device) $21.87
- SYNERGY (Device) $19.01
- Tryton Side Branch Stent (Device) $18.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Philadelphia
Pitamber Devgon, Md, MD
Internal Medicine — Payments: $7.5M
Dr. David Horn, M.d, M.D
Internal Medicine — Payments: $1.7M
Daniel Rader, Md, MD
Internal Medicine — Payments: $1.6M
Corey Langer, Md, MD
Internal Medicine — Payments: $742,647
Dr. Intekhab Ahmed, M.d, M.D
Internal Medicine — Payments: $621,997
David Goldmann, Md, MD
Internal Medicine — Payments: $587,696